Evidence map›Paper›PMID 34964236›Full record

ArticleHIV medicine2022

Failure to return pillbox is a predictor of being lost to follow-up among people living with HIV on antiretroviral therapy in rural Tanzania.

Robert C Ndege, James Okuma, Aneth V Kalinjuma, Julius Mkumbo, Elizabeth Senkoro, Gideon Fue, Leila Samson, Herry Mapesi, Siraji Shabani, Tracy R Glass and 5 more

Abstract read
In one paragraph

Article in HIV medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Robert C NdegeIfakara Health Institute, Ifakara Branch, Ifakara, Tanzania.
James OkumaSwiss Tropical and Public Health Institute, Basel, Switzerland.
Aneth V KalinjumaIfakara Health Institute, Ifakara Branch, Ifakara, Tanzania.
Julius MkumboIfakara Health Institute, Ifakara Branch, Ifakara, Tanzania.
Elizabeth SenkoroIfakara Health Institute, Ifakara Branch, Ifakara, Tanzania.
Gideon FueSt. Francis Referral Hospital, Ifakara, Tanzania.
Leila SamsonIfakara Health Institute, Ifakara Branch, Ifakara, Tanzania.
Herry MapesiIfakara Health Institute, Ifakara Branch, Ifakara, Tanzania.
Siraji ShabaniMinistry of Health, National AIDS Control Program, Dar es Salaam, Tanzania.
Tracy R GlassSwiss Tropical and Public Health Institute, Basel, Switzerland.
Manuel BattegayDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.
Daniel H ParisSwiss Tropical and Public Health Institute, Basel, Switzerland.ORCID 0000-0003-4743-5987
Fiona VanobberghenSwiss Tropical and Public Health Institute, Basel, Switzerland.
Maja WeisserIfakara Health Institute, Ifakara Branch, Ifakara, Tanzania.ORCID 0000-0002-0134-1929
KIULARCO Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesPill count is used to assess drug adherence in people living with HIV (PLHIV). Carrying a pillbox is associated with fear of concealment and stigma and might indicate poor adherence and predict someone who will be lost to follow-up (LTFU). We therefore assessed the association between pillbox return and being LTFU in rural Tanzania.

methodsThis is a nested study of the Kilombero and Ulanga Antiretroviral Cohort (KIULARCO). We included PLHIV aged ≥ 18 years enrolled in KIULARCO between January 2013 and March 2019 with follow-up through January 2020, who were on antiretroviral treatment (ART) for ≥ 6 months. Baseline was defined as the latest ART initiation or KIULARCO enrolment. We determined the association between time-dependent failed pillbox return updated at every visit and LTFU using Kaplan-Meier estimation and Cox models.

resultsAmong 2552 PLHIV included in the study, 1735 (68.0%) were female, 959 (40.3%) had a WHO stage III/IV and 1487 (66.4%) had a CD4 cell count < 350 cells/µL. The median age was 38.4 years [interquartile range (IQR): 31.7-46.2]. During a median follow-up of 33.1 months (IQR: 17.5-52.4), 909 (35.6%) participants were LTFU, 43 (1.7%) died and 194 (7.6%) had transferred to another clinic. The probability of being LTFU was higher among PLHIV with failed pillbox return than among those who returned their pillbox [30.0%, 95% confidence interval (CI): 26.8-33.2% vs. 19.4%, 95% CI: 17.4-21.6%, respectively, at 24 months (hazard ratio = 1.67, 95% CI: 1.46-1.90; p < 0.001)].

conclusionsFailed pillbox return was associated with a higher risk of being LTFU and could be used as a simple tool to identify PLHIV for appropriate interventions to reduce their chance of being LTFU.

Indexed as

HIV InfectionsAdultAnti-Retroviral AgentsCD4 Lymphocyte CountFemaleHumansLost to Follow-UpMaleTanzaniaAnti-Retroviral Agentsadherenceantiretroviral treatmentHIV treatment outcomelost to follow-uppillboxruralstigmasub-Saharan Africa

Identifiers

PMID34964236
PMCPMC9306592

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.